HIGHLIGHTS
- who: Paulina Pawelec and colleagues from the (UNIVERSITY) have published the Article: Analysis of Givinostat/ITF2357 Treatment in a Rat Model of Neonatal Hypoxic-Ischemic Brain Damage, in the Journal: (JOURNAL)
- what: The aim of the study was to test the hypothesis that the mechanism of Givinostat is associated with the alleviation of inflammation. The aim of this study was to elucidate whether a new compound, a histone deacetylase inhibitor, Givinostat (also known as ITF 2357), can diminish neural inflammatory responses in_vivo in neonatal HI together with the molecular consequences of this action. The authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.